BioXcel Therapeutics (BTAIQ) Operating Leases (2019 - 2024)
BioXcel Therapeutics' Operating Leases came in at $65,000 for Q4 2024, down 85.2% from $440,000 a year earlier and down 59.6% from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Operating Leases (2019 - 2024) Analysis & Trends
Going back to Q1 2019, BioXcel Therapeutics' Operating Leases data covers 24 quarters.
- Operating Leases has declined in each of the last four years, with a five-year compound annual growth rate of -42.4% (FY2019 to FY2024).
- Going back by year, Operating Leases was $440,000 in FY2023 (-44.0%), $786,000 in FY2022 (-28.9%), $1.11 million in FY2021 (-21.0%) and $1.4 million in FY2020 (+35.9%).
- The Q4 2024 figure represents the lowest quarterly Operating Leases in data going back to Q1 2019.
- Year-over-year, Operating Leases has declined for 14 consecutive quarters, with an average decline of 51.6% over the last eight quarters.
- The fastest year-over-year change in Operating Leases over five years came in Q2 2021 (growth of 38.4%), and the weakest in Q4 2024 (a decline of 85.2%).
- Business Quant data shows BTAIQ's Operating Leases at $161,000 (Q3 2024), $256,000 (Q2 2024) and $350,000 (Q1 2024) in the three quarters before Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 65,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 256,000.00 |
| Mar 31, 2024 | 350,000.00 |
| Dec 31, 2023 | 440,000.00 |
| Sep 30, 2023 | 529,000.00 |
| Jun 30, 2023 | 617,000.00 |
| Mar 31, 2023 | 703,000.00 |
| Dec 31, 2022 | 786,000.00 |
| Sep 30, 2022 | 868,000.00 |
| Jun 30, 2022 | 949,000.00 |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 1.11 Mn |
| Sep 30, 2021 | 1.18 Mn |
| Jun 30, 2021 | 1.26 Mn |
| Mar 31, 2021 | 1.33 Mn |
| Dec 31, 2020 | 1.40 Mn |
| Sep 30, 2020 | 1.47 Mn |
| Jun 30, 2020 | 907,000.00 |
| Mar 31, 2020 | 961,000.00 |
API Access
BioXcel Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();